CPA
VCEL icon

Capital Performance Advisors’s Vericel Corp VCEL Stock Holding History

Capital Performance Advisors’s Portfolio VCEL Stock Details VCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7
Closed -$296 – 2584
2024
Q3 		$296 Buy
+7
New +$333 ﹤0.01% 2466

Other funds holding VCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Capital Performance Advisors's VCEL Position: Q4 2024 in Review

Capital Performance Advisors sold out of Vericel Corp (VCEL) in Q4 2024, closing a stake of 7 shares — an estimated $296 sold.

Capital Performance Advisors first reported a position in VCEL in Q3 2024 and held it in 1 quarter. The position peaked at $296 in Q3 2024. 278 funds tracked by Wall St. Rank hold VCEL as of Q4 2024.

  • Capital Performance Advisors reported no remaining Vericel Corp position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 7 Vericel Corp shares in Q4 2024, an estimated $296.
  • Capital Performance Advisors first reported a position in Vericel Corp in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Vericel Corp position peaked at $296 in Q3 2024.
  • 278 funds tracked by Wall St. Rank held Vericel Corp as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.